Back
Rocket Pharmaceuticals Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
48
RCKT
Rocket Pharmaceuticals
Last Price:
22.56
Seasonality Move:
12.54%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight buying pressure.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.65 | Sell |
| 20-day SMA: | 23.65 | Sell |
| 50-day SMA: | 26.14 | Sell |
| 200-day SMA: | 23.11 | Sell |
| 8-day EMA: | 22.54 | Sell |
| 20-day EMA: | 23.63 | Sell |
| 50-day EMA: | 25.27 | Sell |
| 200-day EMA: | 24.13 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.17 | Sell |
| Relative Strength Index (14 RSI): | 38.6 | Sell |
| Chaikin Money Flow: | 3050 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.66 - 25.74) | Sell |
| Bollinger Bands (100): | (25.06 - 29.66) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 22.52 while RCKT 8-day simple moving average is 22.65, which is a Sell signal.
- The stock price of RCKT is 22.52 while Rocket Pharmaceuticals 20-day SMA is 23.65, which makes it a Sell.
- Rocket Pharmaceuticals 50-day simple moving average is 26.14 while RCKT share price is 22.52, making it a Sell technically.
- RCKT stock price is 22.52 and Rocket Pharmaceuticals 200-day simple moving average is 23.11, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
48
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Sell
The current Rocket Pharmaceuticals [RCKT] share price is $22.52. The Score for RCKT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
2.04B
Price in USD:
22.52
Share Volume:
631.3K
Rocket Pharmaceuticals 52-Week Range
52-Week High:
32.53
52-Week Low:
14.89
Sell
48
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?
The Rocket Pharmaceuticals stock price is 22.52 USD today. -
Will RCKT stock go up or go down?
Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rocket Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 22.52 while RCKT 8-day exponential moving average is 22.54, which is a Sell signal.
- The stock price of RCKT is 22.52 while Rocket Pharmaceuticals 20-day EMA is 23.63, which makes it a Sell.
- Rocket Pharmaceuticals 50-day exponential moving average is 25.27 while RCKT share price is 22.52, making it a Sell technically.
- RCKT stock price is 22.52 and Rocket Pharmaceuticals 200-day simple moving average is 24.13, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
- RCKT Moving Average Covergence Divergence (MACD) indicator is -1.17, suggesting Rocket Pharmaceuticals is a Sell
- Rocket Pharmaceuticals Relative Strength Index (RSI) is 38.6, which suggest Rocket Pharmaceuticals is oversold
- The Bollinger Bands (25) for Rocket Pharmaceuticals is (22.66 - 25.74), which suggest Rocket Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Rocket Pharmaceuticals is (25.06 - 29.66), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.